Comparison of the Performance and Safety of T2769 Versus Vismed® Multi in the Treatment of Moderate to Severe Dry Eye Syndrome - Trial NCT05965778
Access comprehensive clinical trial information for NCT05965778 through Pure Global AI's free database. This phase not specified trial is sponsored by Laboratoires Thea and is currently Not yet recruiting. The study focuses on Dry Eye. Target enrollment is 226 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Laboratoires Thea
Timeline & Enrollment
N/A
Sep 01, 2023
Aug 01, 2024
Primary Outcome
Change from baseline (Day 1) in total ocular surface staining grade according to Oxford 0-15 grading scheme.
Summary
To demonstrate the non-inferiority of T2769 compared to Vismed® Multi in terms of total
 ocular surface staining (Oxford score) after 35 days of treatment.
 
 To evaluate the performance and safety of T2769 versus Vismed® Multi.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05965778
Device Trial